A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

Youn Ho Kim, Woo Sik Han, Sun Jae Lee, Sung Nam Oh, Do Won Choi, Kwan Soo Byun, Jong Eun Yeon

    Research output: Contribution to journalArticlepeer-review

    Abstract

    There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

    Original languageEnglish
    Pages (from-to)419-422
    Number of pages4
    JournalThe Korean journal of hepatology
    Volume13
    Issue number3
    DOIs
    Publication statusPublished - 2007 Sep

    ASJC Scopus subject areas

    • Medicine(all)

    Fingerprint

    Dive into the research topics of 'A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin'. Together they form a unique fingerprint.

    Cite this